Abdel-Razik, A., Mousa, N., Abdelsalam, M., Abdelwahab, A., Tawfik, M., Tawfik, A. M., . . . Eldars, W. (2020). Endothelin-1/Nitric Oxide Ratio as a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome. Front Pharmacol.
シカゴスタイル引用形Abdel-Razik, Ahmed, et al. "Endothelin-1/Nitric Oxide Ratio As a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome." Front Pharmacol 2020.
MLA引用形式Abdel-Razik, Ahmed, et al. "Endothelin-1/Nitric Oxide Ratio As a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome." Front Pharmacol 2020.
警告: この引用は必ずしも正確ではありません.